94236-25-6

Basic information

• Product Name: Butanoic acid, 4-[4-[(2,4-diamino-5-pyrimidinyl)methyl]-2,6-dimethoxyphenoxy]-, ethyl ester
• CAS NO: 94236-25-6
• Molecular Formula: C19H26N4O5
• Molecular Weight: 390.439
• Mol File: 94236-25-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Butanoic acid, 4-[4-[(2,4-diamino-5-pyrimidinyl)methyl]-2,6-dimethoxyphenoxy]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Butanoic acid, 4-[4-[(2,4-diamino-5-pyrimidinyl)methyl]-2,6-dimethoxyphenoxy]-, ethyl ester(94236-25-6)
• EPA Substance Registry System: Butanoic acid, 4-[4-[(2,4-diamino-5-pyrimidinyl)methyl]-2,6-dimethoxyphenoxy]-, ethyl ester(94236-25-6)

Safety Data

• Hazardous Substances Data: 94236-25-6(Hazardous Substances Data)

Upstream product

• 738-70-5 5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine 
• 2969-81-5 Ethyl 4-bromobutyrate 
• 21253-58-7 2,4-diamino-5-(3,5-dimethoxy-4-hydroxybenzyl)pyrimidine 

Downstream Products

• 94236-24-5 4-(4-((2,4-diaminopyrimidin-5-yl)methyl)-2,6-dimethoxyphenoxy)butanoic acid 

Relevant articles and documents

Broad-spectrum monoclonal antibody and a sensitive multi-residue indirect competitive enzyme-linked immunosorbent assay for the antibacterial synergists in samples of animal origin

To monitor the abuse of antibacterial synergists, a hapten, trimethoprim carboxylic derivative (TMPCOOH), was designed by using molecular modelling technology. A broad-spectrum monoclonal antibody (mAb) TMP/2G1 was prepared, for which the IC50

Receptor-based design of dihydrofolate reductase inhibitors: Comparison of crystallographically determined enzyme binding with enzyme affinity in a series of carboxy-substituted trimethoprim analogues

By the use of molecular models of Escherichia coli dihydrofolate reductase (DHFR), analogues of trimethoprim (TMP) were designed which incorporated various 3'-carboxyalkoxy moieties in order to acquire ionic interactions with positively charged active-sit